Myelin-oligodendrocyte glycoprotein antibody-associated disease / 中华神经科杂志
Chinese Journal of Neurology
;
(12): 643-649, 2022.
Article
in Chinese
| WPRIM
| ID: wpr-933834
ABSTRACT
Myelin-oligodendrocyte glycoprotein antibody-associated disease (MOGAD) is a recently-established autoimmune central nervous system demyelinating disease, characterized by the detection of serum anti-myelin-oligodendrocyte glycoprotein antibody of IgG1 type. Sharing similar clinical manifestations with multiple sclerosis and aquaporin-4 antibody positive neuromyelitis optica spectrum disorder, it has yet demonstrated a unique disease course, pathological and radiological features. Therefore, MOGAD should be regarded as a disease entity to carry out further investigation. This review intends to summarize its pathogenesis, diagnosis and treatment progresses, so as to provide guidance for clinical practice.
Full text:
Available
Index:
WPRIM (Western Pacific)
Type of study:
Practice guideline
Language:
Chinese
Journal:
Chinese Journal of Neurology
Year:
2022
Type:
Article
Similar
MEDLINE
...
LILACS
LIS